Targeting Glycoprotein NMB With Antibody-Drug Conjugate, Glembatumumab Vedotin, for the Treatment of Osteosarcoma

Michael Roth, David M. Barris, Sajida Piperdi, Vicky Kuo, Stephanie Everts, David Geller, Peter Houghton, E. Anders Kolb, Thomas Hawthorne, Jonathan Gill, Richard Gorlick

Research output: Contribution to journalArticlepeer-review

28 Scopus citations

Fingerprint Dive into the research topics of 'Targeting Glycoprotein NMB With Antibody-Drug Conjugate, Glembatumumab Vedotin, for the Treatment of Osteosarcoma'. Together they form a unique fingerprint.

Medicine & Life Sciences